Show simple item record

dc.contributor.authorCandan F.
dc.contributor.authorKaptanoglu M.
dc.contributor.authorEgilmez R.
dc.contributor.authorDogan K.
dc.contributor.authorAksoy M.
dc.contributor.authorYalman Y.
dc.contributor.authorBekar E.
dc.contributor.authorGultekin F.
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T09:13:29Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T09:13:29Z
dc.date.issued1998
dc.identifier.issn1300-0144
dc.identifier.urihttps://hdl.handle.net/20.500.12418/4716
dc.description.abstractDexfenfluramine is a variation of fenfluramine which is used for weight reduction. The aim of the study is to determine the hemodynamic and structural effects of this drug on pulmonary circulation. An experimental study was carried out with New Zealand Rabbits. A control group (n=30) and an experimental group (n=20) was constituted. A four-week normal diet for control group and dexfenfluramine plus normal diet for experimental group were applied. Body weights and pulmonary artery pressures of groups were recorded and lungs were collected for pathologic examination. In experimental group: Dexfenfluramine raised systolic pulmonary artery pressures significantly (p<0.01), whereas, there were no meaningful changes on diastolic and mean pulmonary artery pressures (p>0.05). Weight reduction was obvious (f= 8.522, p<0.01), in experimental group. There were marked histopathologic changes in accordance with pulmonary hypertension. In addition, squamouse metaplasia (n=1) and tumorlet (n=3) formations were seen. The use of dexfenfluramine was associated with the development of primary pulmonary hypertension. Duration and dosage relations of the therapy and topical effects of the drug should be investigated with further studies. The reasons of tumorlet formation and squamouse metaplasia must be explained with new researches.en_US
dc.language.isoengen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAppetite depressantsen_US
dc.subjectDexfenfluramineen_US
dc.subjectFenfluramineen_US
dc.subjectObesityen_US
dc.subjectPulmonary hypertensionen_US
dc.titlePulmonary effects of dexfenfluramineen_US
dc.typearticleen_US
dc.relation.journalTurkish Journal of Medical Sciencesen_US
dc.contributor.departmentCandan, F., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey -- Kaptanoglu, M., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey -- Egilmez, R., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey -- Dogan, K., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey -- Aksoy, M., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey -- Yalman, Y., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey -- Bekar, E., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkey -- Gultekin, F., Department of Internal Medicine, Faculty of Medicine, Cumhuriyet University, Sivas, Turkeyen_US
dc.identifier.volume28en_US
dc.identifier.issue3en_US
dc.identifier.endpage246en_US
dc.identifier.startpage239en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record